Antiviral drugs

Details

• Personal Author:
  Noti JD ; Othumpangat S ; Ray SD
• Description:
  Topical cidofovir treatment in herpes simples virus infections resulted in irreversible acute kidney injury. A 58-year-old man underwent a matched unrelated donor (MUD) stem cell transplant for secondary myelodysplastic syndrome. His conditioning regimen consisted of busulfan, fludarabine, and antithymocyte globulin. The patient received oral valganciclovir during the peritransplantation phase at a dose of 900 mg twice daily for CMV prophylaxis, and prophylactic valacyclovir was initiated on day 1. The patient was readmitted within 2 weeks of his initial hospital discharge with neutropenic fever, worsening mucositis, and acute cutaneous graft-versushost disease (GVHD). The patient was treated with intravenous (IV) acyclovir at 5 mg/kg followed by antiviral therapy containing 5% cidofovir administered as oral gel. [Description provided by NIOSH]
• Subjects:
  Communicable Diseases HIV Occupational Health Preventive Medicine Safety Viral Diseases
• Keywords:
  Adverse Reactions Amprenavir Antiretroviral Drugs Atazanavir Author Keywords: Adefovir Boceprevir Chemokine Receptor CCR5 Antagonists Cidofovir Cytomegalovirus Darunavir Didanosine Dolutegravir Drugs Efavirenz Emtricitabine Enfuvirtide Etravirine Famciclovir Fosamprenavir Foscarnet Ganciclovir Hepatitis Viruses Herpesviruses Imiquimod Indinavir Infection-control Infectious-diseases Influenza Viruses Inhibitors Of HIV Fusion Integrase Inhibitors Ion Channel Inhibitors Kidney Damage Lamivudine Lopinavir Maraviroc Nelfinavir Neuraminidase Inhibitors Nevirapine Non-nucleoside Reverse Transcriptase Inhibitors Nucleoside Analogue Reverse Transcriptase Inhibitors Nucleotide Analogue Reverse Transcriptase Inhibitor Oseltamivir Preventive-medicine Protease Inhibitors Raltegravir Ribavirin Rilpivirine Ritonavir Simeprevir Sofosbuvir Stavudine Stem Cells Surgery Telaprevir Tenofovir Tipranavir Treatment Valaciclovir Valganciclovir Viral-diseases Viral-infections

  More +
• ISBN:
  9780444635259
• ISSN:
  0378-6080
• Publisher:
  Elsevier
• Document Type:
  Text
• Genre:
  Book
• Place as Subject:
  Massachusetts ; OSHA Region 1 ; OSHA Region 3 ; West Virginia
• CIO:
  National Institute for Occupational Safety and Health (NIOSH)
• Division:
  HELD - Health Effects Laboratory Division
• Topic:
  Workplace Safety & Health
• Location:
  North America
• Pages in Document:
  329-348
• Volume:
  37
• NIOSHTIC Number:
  nn:20047032
• Citation:
  Side effects of drugs annual: a worldwide yearly survey of new data in adverse drug reactions, first edition. Ray SD, Gray JP, Kiersma ME, Dukes MNG, eds. Waltham, MA: Elsevier, 2015 Nov; 37:329-348
• Contact Point Address:
  Sreekumar Othumpangat, Allergy and Clinical Immunology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Road, Morgantown, WV 26505
• Email:
  seo8@cdc.gov
• Editor(s):
  Ray SD; Gray JP; Kiersma ME; Dukes MNG
• Federal Fiscal Year:
  2016
• NORA Priority Area:
  Healthcare and Social Assistance
• Peer Reviewed:
  True
• Source Full Name:
  Side effects of drugs annual: a worldwide yearly survey of new data in adverse drug reactions, first edition
• Collection(s):
  National Institute for Occupational Safety and Health
• Main Document Checksum:
  urn:sha-512:cdb2d1fbeef1577f33cda4253a4ecab15012edc0a46d56995706e6149939ca313e1b86fb0af29d3759167bcaf589a9e79977aaa6b7f3d439aea52f3fe859c23a
• Download URL:
  https://stacks.cdc.gov/view/cdc/202264/cdc_202264_DS1.pdf
• File Type:
  [PDF - 206.53 KB ]